XNYS
AGL
Market cap902mUSD
Jul 22, Last price
2.18USD
1D
1.87%
1Q
-44.39%
IPO
-92.73%
Name
agilon health inc
Chart & Performance
P/E
—
P/S
0.15
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.01%
Rev. gr., 5y
50.14%
Revenues
6.06b
+40.41%
Net income
-260m
L-0.95%
CFO
-58m
L-63.01%
Dividend
Nov 16, 20110.45 USD/sh
Earnings
Aug 04, 2025
Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 6,060,530 40.41% | 4,316,363 59.38% | 2,708,211 47.70% | |||
Cost of revenue | 6,324,601 | 4,532,453 | 2,814,870 | |||
Unusual Expense (Income) | ||||||
NOPBT | (264,071) | (216,090) | (106,659) | |||
NOPBT Margin | ||||||
Operating Taxes | 1,451 | 791 | 1,175 | |||
Tax Rate | ||||||
NOPAT | (265,522) | (216,881) | (107,834) | |||
Net income | (260,101) -0.95% | (262,596) 145.73% | (106,864) -73.65% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 1,167 | (188,133) | 33,056 | |||
BB yield | -0.15% | 3.67% | -0.50% | |||
| Debt | ||||||
Debt current | 9,096 | 5,000 | ||||
Long-term debt | 48,102 | 54,118 | 48,367 | |||
Deferred revenue | ||||||
Other long-term liabilities | 69,522 | 59,476 | 83,286 | |||
Net debt | (351,866) | (469,882) | (872,956) | |||
| Cash flow | ||||||
Cash from operating activities | (57,777) | (156,199) | (130,808) | |||
CAPEX | (13,251) | (15,830) | (32,661) | |||
Cash from investing activities | 139,891 | (44,019) | (444,388) | |||
Cash from financing activities | (2,583) | (193,133) | 28,056 | |||
FCF | (229,031) | (249,279) | (130,935) | |||
| Balance | ||||||
Cash | 399,968 | 488,343 | 908,971 | |||
Long term investments | 44,753 | 17,352 | ||||
Excess cash | 96,942 | 317,278 | 790,912 | |||
Stockholders' equity | (1,582,943) | (1,325,878) | (1,066,277) | |||
Invested Capital | 2,164,920 | 2,098,684 | 2,233,654 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 410,966 | 408,917 | 408,154 | |||
Price | 1.90 -84.86% | 12.55 -22.24% | 16.14 -40.22% | |||
Market cap | 780,835 -84.78% | 5,131,908 -22.10% | 6,587,606 -39.02% | |||
EV | 428,969 | 4,661,208 | 5,714,039 | |||
EBITDA | (239,608) | (195,929) | (92,887) | |||
EV/EBITDA | ||||||
Interest | 6,177 | 6,658 | 4,525 | |||
Interest/NOPBT | ||||||